TABLE 4.
Length and gain in length of 63 infants who completed the intervention to 5.5 mo1
| Length, 1 mo |
Length, 5.5 mo |
Length gain, 1–5.5 mo (percentile change) |
|||
| Fe | Plac | Fe | Plac | Fe | Plac |
| cm | cm | mm/d | |||
| Males | |||||
| 53.1 ± 2.9 | 55.5 ± 1.52 | 65.5 ± 2.7 | 67.3 ± 2.12 | 0.882 ± 0.098 | 0.843 ± 0.103 |
| (39.7) | (64.5) | (43.4) | (62.6)2 | (+3.7) | (−1.9) |
| Females | |||||
| 53.2 ± 1.5 | 53.7 ± 1.4 | 64.2 ± 1.5 | 64.8 ± 1.6 | 0.786 ± 0.072 | 0.792 ± 0.061 |
| (49.5) | (56.6) | (46.3) | (55.0) | (−3.2) | (−1.6) |
| Both sexes | |||||
| (44.8) | (60.3)2 | (44.9) | (58.6)2 | (+0.1) | (−1.7) |
1
Values in parentheses are mean percentile values, calculated on the basis of the Centers for Disease Control and Prevention growth reference (24). All other values are means ± SDs. Fe, iron supplementation group; Plac, placebo group.
2
Significantly different from corresponding value in Fe group, P < 0.05 (ANOVA and F test).